一名接受家庭医疗护理患者体内的万古霉素中介金黄色葡萄球菌。
Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
作者信息
Hageman J C, Pegues D A, Jepson C, Bell R L, Guinan M, Ward K W, Cohen M D, Hindler J A, Tenover F C, McAllister S K, Kellum M E, Fridkin S K
机构信息
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
出版信息
Emerg Infect Dis. 2001 Nov-Dec;7(6):1023-5. doi: 10.3201/eid0706.010618.
Abstract
In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types. The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission.
摘要
2000年6月，在一名27岁的家庭保健患者进行复杂胆囊切除术后，分离出了万古霉素中介金黄色葡萄球菌（VISA）。鉴定出两株VISA菌株，它们对除苯唑西林外的所有测试抗菌药物的最低抑菌浓度相同，且脉冲场凝胶电泳类型密切相关。该患者通过抗菌治疗、胆汁引流和重建手术成功治愈。家庭保健环境中的标准预防措施似乎成功地防止了传播。
相似文献
1
Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.一名接受家庭医疗护理患者体内的万古霉素中介金黄色葡萄球菌。
Emerg Infect Dis. 2001 Nov-Dec;7(6):1023-5. doi: 10.3201/eid0706.010618.
2
Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.台湾某医院耐甲氧西林金黄色葡萄球菌和万古霉素中介金黄色葡萄球菌的克隆传播。
Int J Antimicrob Agents. 2010 Oct;36(4):307-12. doi: 10.1016/j.ijantimicag.2010.06.035. Epub 2010 Aug 3.
3
Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus.一株USA300万古霉素中介金黄色葡萄球菌的出现。
Diagn Microbiol Infect Dis. 2008 Dec;62(4):440-2. doi: 10.1016/j.diagmicrobio.2008.08.005. Epub 2008 Oct 7.
4
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.金黄色葡萄球菌中万古霉素耐药性的出现。糖肽类中介金黄色葡萄球菌工作组。
N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701.
5
Key considerations in the treatment of complicated staphylococcal infections.复杂性葡萄球菌感染治疗中的关键考量因素。
Clin Microbiol Infect. 2008 Mar;14 Suppl 2:3-9. doi: 10.1111/j.1469-0691.2008.01923.x.
6
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.万古霉素中介及耐万古霉素金黄色葡萄球菌的出现。
Clin Microbiol Infect. 2006 Mar;12 Suppl 1:16-23. doi: 10.1111/j.1469-0691.2006.01344.x.
7
hVISA/VISA: diagnostic and therapeutic problems.高毒力/万古霉素中介金黄色葡萄球菌：诊断与治疗问题
Expert Rev Anti Infect Ther. 2009 Feb;7(1):1-3. doi: 10.1586/14787210.7.1.1.
8
Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.2001 年至 2006 年韩国医院万古霉素中介金黄色葡萄球菌菌株的全国监测研究。
J Microbiol Biotechnol. 2010 Mar;20(3):637-42.
9
Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.万古霉素中介及耐药金黄色葡萄球菌：传染病专家需要了解的内容。
Clin Infect Dis. 2001 Jan;32(1):108-15. doi: 10.1086/317542. Epub 2000 Dec 13.
10
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.2001年至2005年期间，非万古霉素中介金黄色葡萄球菌（VISA）、对万古霉素敏感的临床耐甲氧西林金黄色葡萄球菌（MRSA）血源分离株中万古霉素最低抑菌浓度（MIC）的缓慢上升。
J Antimicrob Chemother. 2007 Oct;60(4):788-94. doi: 10.1093/jac/dkm258. Epub 2007 Jul 10.
引用本文的文献
1
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.万古霉素耐药、万古霉素中介和异质性万古霉素中介金黄色葡萄球菌临床分离株的全球流行率和分布：系统评价和荟萃分析。
Sci Rep. 2020 Jul 29;10(1):12689. doi: 10.1038/s41598-020-69058-z.
2
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine.嗜铬细胞瘤/副神经节瘤的当前管理：精准医学时代执业临床医生指南
Cancers (Basel). 2019 Oct 8;11(10):1505. doi: 10.3390/cancers11101505.
3
The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study.万古霉素谷浓度对非深部感染结局的影响：一项回顾性队列研究。
BMC Pharmacol Toxicol. 2018 Jul 31;19(1):47. doi: 10.1186/s40360-018-0236-z.
4
The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.msaABCR操纵子调节万古霉素中介金黄色葡萄球菌菌株的耐药性。
Antimicrob Agents Chemother. 2014 Nov;58(11):6685-95. doi: 10.1128/AAC.03280-14. Epub 2014 Aug 25.
5
Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals.从不同伊朗医院分离出的耐甲氧西林和敏感、万古霉素中介金黄色葡萄球菌菌株的基因特征分析
ISRN Microbiol. 2012 Dec 20;2012:215275. doi: 10.5402/2012/215275. Print 2012.
6
Utility of the Etest GRD for detecting Staphylococcus aureus with reduced susceptibility to glycopeptides in cystic fibrosis patients.Etest GRD 检测法在检测囊性纤维化患者中糖肽类药物低敏性金黄色葡萄球菌中的应用。
Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):599-604. doi: 10.1007/s10096-011-1353-4. Epub 2011 Sep 9.
7
Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis.从菌血症和心内膜炎中改变意大利医院社区的趋势和金黄色葡萄球菌的异质性耐药性。
Eur J Clin Microbiol Infect Dis. 2012 May;31(5):739-45. doi: 10.1007/s10096-011-1367-y. Epub 2011 Aug 7.
8
Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis.治疗复发性耐甲氧西林金黄色葡萄球菌菌血症导致的胆囊炎的注意事项。
J Gen Intern Med. 2011 Jun;26(6):669-72. doi: 10.1007/s11606-011-1634-8. Epub 2011 Jan 19.
9
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.金黄色葡萄球菌中万古霉素敏感性降低，包括万古霉素中介和异质性万古霉素中介菌株：耐药机制、实验室检测及临床意义。
Clin Microbiol Rev. 2010 Jan;23(1):99-139. doi: 10.1128/CMR.00042-09.
10
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.《2007年隔离预防指南：医疗机构中预防感染性因子的传播》
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164. doi: 10.1016/j.ajic.2007.10.007.
本文引用的文献
1
Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.对万古霉素敏感性降低的金黄色葡萄球菌——伊利诺伊州，1999年
MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7.
2
Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.万古霉素中介及耐药金黄色葡萄球菌：传染病专家需要了解的内容。
Clin Infect Dis. 2001 Jan;32(1):108-15. doi: 10.1086/317542. Epub 2000 Dec 13.
3
Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.从一名患有致命菌血症的患者身上分离出的对万古霉素敏感性降低的金黄色葡萄球菌。
Emerg Infect Dis. 1999 Jan-Feb;5(1):147-9. doi: 10.3201/eid0501.990118.
4
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.金黄色葡萄球菌中万古霉素耐药性的出现。糖肽类中介金黄色葡萄球菌工作组。
N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701.
5
Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin.耐万古霉素葡萄球菌感染预防与控制临时指南
MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):626-8, 635.
6
Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.1996年日本金黄色葡萄球菌对万古霉素的敏感性降低
MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):624-6.
7
Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.通过多重聚合酶链反应对耐甲氧西林葡萄球菌进行特异性检测。
J Clin Microbiol. 1995 Nov;33(11):2864-7. doi: 10.1128/jcm.33.11.2864-2867.1995.
8
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.解读脉冲场凝胶电泳产生的染色体DNA限制性图谱：细菌菌株分型标准
J Clin Microbiol. 1995 Sep;33(9):2233-9. doi: 10.1128/jcm.33.9.2233-2239.1995.
Zotero 插件